In this paper, the estimation of the maximum tolerated dose of a drug for phase I clinical trials is investigated.
这篇论文主要研究的是第i阶段临床试验中最大耐受剂量的估计问题。
Studies on phase I clinical trials of artesunate tablet were carried out with double blind method in 22 male healthy volunteers.
以双盲法对22名健康男性志愿者进行青蒿琥酯片口服的耐受性和不良反应研究。
Methods Retrospective review of transaminase data collected on placebo during 2 phase I clinical trials in 16 healthy volunteers, who were either hospitalized for 2 days or 13 days.
方法在2个新药I期临床试验中,对多次服用安慰剂、住院时间为2天或13天的16名健康志愿者多次进行转氨酶检查。
应用推荐